{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:29:38Z","timestamp":1793104178686,"version":"4.5.0"},"reference-count":73,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Mailing human papillomavirus (HPV) self-sampling kits increases cervical cancer screening participation, but effects may differ across subpopulations. Subpopulation data can inform US health care system implementation.<\/jats:p><\/jats:sec>Objective<\/jats:title>To identify patient characteristics that modify effectiveness of a mailed kit intervention at increasing screening.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This was a secondary analysis of data from the Home-Based Options to Make Cervical Cancer Screening Easy (HOME) randomized clinical trial conducted from 2014 to 2018 at Kaiser Permanente Washington. Data analysis was performed from March 2018 to May 2022. Individuals aged 30 to 64 years with female sex, health plan enrollment longer than 3 years and 5 months, a current primary care clinician, and no Papanicolaou test within the prior 3 years and 5 months were identified through electronic medical records and randomized (1:1) to the control or intervention group.<\/jats:p><\/jats:sec>Interventions<\/jats:title>The control group received usual care Papanicolaou screening reminders and outreach. The intervention group received usual care plus an unsolicited mailed HPV self-sampling kit.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Screening uptake was captured within 6 months after randomization. Baseline patient characteristics (age, race, ethnicity, travel time to clinic, income, body mass index, tobacco use, health plan enrollment duration, time since last Papanicolaou test, mammography, comorbidities, and colorectal cancer screening adherence) were extracted from the electronic medical record.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 19\u202f734 individuals (mean [SD] age, 50.1 [9.5] years; 14\u202f129 [71.6%] White), 9843 were randomized to the intervention group, and 9891 were randomized to the control group. Screening uptake was 26.3% (2592 of 9843 individuals) in the intervention group vs 17.4% (1719 of 9891 individuals) in the control group (relative risk [RR], 1.51; 95% CI, 1.43-1.60). Although absolute differences in uptake by group varied little by screening history, relative effects were greater with longer vs shorter time since last Papanicolaou test (no prior Papanicolaou test: RRs, 1.85-3.25; \u226510 years: RR, 2.78; 5-10 years: RRs, 1.69-1.86; &amp;lt;5 years: RRs 1.29-1.37). Relative effects were greater in participants overdue (RR, 2.03; 95% CI, 1.73-2.38) vs up-to-date with mammography (RR, 1.53; 95% CI, 1.41-1.67), although absolute difference was greater in the up-to-date group. Differences by age were not significant, with RRs of 1.33 to 1.48 across 5-year age groups in participants 30 to 54, vs 1.60 (95% CI, 1.40-1.82) in participants 55 to 59 and 1.77 (95% CI, 1.56-2.01) in participants 60 to 64 years. Among those mailed kits, there were differences in kit use vs in-clinic screening by age, race, plan enrollment duration, underscreening duration, and colorectal cancer screening adherence.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this secondary analysis of a randomized clinical trial, clinically important improvements in screening uptake were observed for all subgroups. Differences in magnitude of intervention effect and kit use highlighted opportunities to optimize HPV self-sampling for priority groups.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier:NCT02005510<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.44343","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T16:32:51Z","timestamp":1669825971000},"page":"e2244343","source":"Crossref","is-referenced-by-count":9,"title":["Effect of Patient Characteristics on Uptake of Screening Using a Mailed Human Papillomavirus Self-sampling Kit"],"prefix":"10.1001","volume":"5","author":[{"given":"Rachel L.","family":"Winer","sequence":"first","affiliation":[{"name":"Department of Epidemiology, University of Washington, Seattle"},{"name":"Kaiser Permanente Washington Health Research Institute, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin A.","family":"Tiro","sequence":"additional","affiliation":[{"name":"Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Miglioretti","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Seattle"},{"name":"Division of Biostatistics, Department of Public Health Sciences, University of California Davis, Davis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Beatty","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Kimbel","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Washington, Seattle"},{"name":"Kaiser Permanente Washington Health Research Institute, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Thayer","sequence":"additional","affiliation":[{"name":"Washington Permanente Medical Group, Renton"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana S. M.","family":"Buist","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"issue":"1","key":"zoi221249r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.43582","article-title":"Assessment of US Preventive Services Task Force guideline-concordant cervical cancer screening rates and reasons for underscreening by age, race and ethnicity, sexual orientation, rurality, and insurance, 2005 to 2019.","volume":"5","author":"Suk","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"7","key":"zoi221249r2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"zoi221249r3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.v70.1","article-title":"Cancer statistics, 2020.","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"zoi221249r4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/jnci\/dji115","article-title":"Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.","volume":"97","author":"Leyden","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"zoi221249r6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1006\/gyno.1998.5135","article-title":"Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC).","volume":"71","author":"Kinney","year":"1998","journal-title":"Gynecol Oncol"},{"issue":"6","key":"zoi221249r7","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2105\/AJPH.85.6.791","article-title":"The screening histories of women with invasive cervical cancer, Connecticut.","volume":"85","author":"Janerich","year":"1995","journal-title":"Am J Public Health"},{"issue":"1","key":"zoi221249r8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/01674820701504619","article-title":"Reasons for non-attendance at cervical screening as reported by non-attendees in Sweden.","volume":"29","author":"Oscarsson","year":"2008","journal-title":"J Psychosom Obstet Gynaecol"},{"issue":"3","key":"zoi221249r9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/BF02895117","article-title":"Barriers to mammography and Pap smear screening among women who recently had neither, one or both types of screening.","volume":"22","author":"Glasgow","year":"2000","journal-title":"Ann Behav Med"},{"issue":"6","key":"zoi221249r10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1006\/pmed.2001.0844","article-title":"Reasons women do not attend screening for cervical cancer: a population-based study in Sweden.","volume":"32","author":"Eaker","year":"2001","journal-title":"Prev Med"},{"issue":"4","key":"zoi221249r11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/pmed.2001.0844","article-title":"Barriers to cervical cancer screening attendance in England: a population-based survey.","volume":"16","author":"Waller","year":"2009","journal-title":"J Med Screen"},{"issue":"11","key":"zoi221249r12","first-page":"745","article-title":"Implementation of systems strategies for breast and cervical cancer screening services in health maintenance organizations.","volume":"9","author":"Goins","year":"2003","journal-title":"Am J Manag Care"},{"issue":"44","key":"zoi221249r13","first-page":"1004","article-title":"Vital signs: cervical cancer incidence, mortality, and screening\u2014United States, 2007-2012.","volume":"63","author":"Benard","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi221249r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106410","article-title":"Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery system.","volume":"145","author":"Malone","year":"2021","journal-title":"Prev Med"},{"issue":"8","key":"zoi221249r15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.15585\/mmwr.mm6608a1","article-title":"Cancer screening test use\u2014United States, 2015.","volume":"66","author":"White","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"zoi221249r16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women.","volume":"106","author":"Datta","year":"2006","journal-title":"Cancer"},{"issue":"9","key":"zoi221249r17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.7326\/0003-4819-132-9-200005020-00003","article-title":"Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care?","volume":"132","author":"Wee","year":"2000","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi221249r18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/LGT.0b013e3181f58d0d","article-title":"Correlation between smoking status and cervical cancer screening: a cross-sectional study.","volume":"15","author":"MacLaughlan","year":"2011","journal-title":"J Low Genit Tract Dis"},{"issue":"3","key":"zoi221249r19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2217\/crc.14.18","article-title":"Examining connections between screening for breast, cervical and prostate cancer and colorectal cancer screening.","volume":"3","author":"Wirth","year":"2014","journal-title":"Colorectal Cancer"},{"issue":"9","key":"zoi221249r20","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1089\/jwh.2007.0603","article-title":"Factors associated with mammography utilization: a systematic quantitative review of the literature.","volume":"17","author":"Schueler","year":"2008","journal-title":"J Womens Health (Larchmt)"},{"key":"zoi221249r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2019.105880","article-title":"Three large scale surveys highlight the complexity of cervical cancer under-screening among women 45-65 years of age in the United States.","volume":"130","author":"Harper","year":"2020","journal-title":"Prev Med"},{"key":"zoi221249r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2021.101652","article-title":"Persistent racial disparities in cervical cancer screening with Pap test.","volume":"24","author":"McDaniel","year":"2021","journal-title":"Prev Med Rep"},{"issue":"6","key":"zoi221249r23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198939","article-title":"Does mammogram attendance influence participation in cervical and colorectal cancer screening? a prospective study among 1856 French women.","volume":"13","author":"Bertaut","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"zoi221249r24","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jacr.2004.05.018","article-title":"Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?","volume":"1","author":"Carlos","year":"2004","journal-title":"J Am Coll Radiol"},{"key":"zoi221249r25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.canep.2016.12.010","article-title":"Association between comorbidity and participation in breast and cervical cancer screening: a systematic review and meta-analysis.","volume":"47","author":"Diaz","year":"2017","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"zoi221249r26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1046\/j.1525-1497.1998.00115.x","article-title":"Chronic disease as a barrier to breast and cervical cancer screening.","volume":"13","author":"Kiefe","year":"1998","journal-title":"J Gen Intern Med"},{"issue":"5","key":"zoi221249r27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3322\/caac.v70.5","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"zoi221249r28","doi-asserted-by":"publisher","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"issue":"2","key":"zoi221249r29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","article-title":"Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial.","volume":"20","author":"Polman","year":"2019","journal-title":"Lancet Oncol"},{"key":"zoi221249r30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104375","article-title":"Analytical performance of HPV assays on vaginal self-collected vs practitioner-collected cervical samples: the SCoPE study.","volume":"127","author":"Saville","year":"2020","journal-title":"J Clin Virol"},{"key":"zoi221249r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106900","article-title":"Worldwide use of HPV self-sampling for cervical cancer screening.","volume":"154","author":"Serrano","year":"2022","journal-title":"Prev Med"},{"key":"zoi221249r32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cct.2017.11.004","article-title":"Rationale and design of the HOME trial: a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.","volume":"64","author":"Winer","year":"2018","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"zoi221249r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.14729","article-title":"Effect of mailed human papillomavirus test kits vs usual care reminders on cervical cancer screening uptake, precancer detection, and treatment: a randomized clinical trial.","volume":"2","author":"Winer","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"11","key":"zoi221249r34","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1158\/1055-9965.EPI-18-0480","article-title":"Determinants for participation in human papillomavirus self-sampling among nonattenders to cervical cancer screening in Denmark.","volume":"27","author":"Harder","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"zoi221249r35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/ijc.31391","article-title":"A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non-participants in the Flemish cervical cancer screening program.","volume":"143","author":"Kellen","year":"2018","journal-title":"Int J Cancer"},{"key":"zoi221249r36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejogrb.2021.11.430","article-title":"Feasibility of sending a direct send HPV self-sampling kit to long-term non-attenders in an organized cervical screening program.","volume":"268","author":"Sahlgren","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"zoi221249r37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001351","article-title":"Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis.","volume":"4","author":"Yeh","year":"2019","journal-title":"BMJ Glob Health"},{"issue":"6","key":"zoi221249r38","doi-asserted-by":"publisher","first-page":"E677","DOI":"10.1002\/ijc.29176","article-title":"Improving cervical cancer screening attendance in Finland.","volume":"136","author":"Virtanen","year":"2015","journal-title":"Int J Cancer"},{"issue":"12","key":"zoi221249r39","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.ejca.2011.11.022","article-title":"Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: characteristics of the responders.","volume":"48","author":"G\u00f6k","year":"2012","journal-title":"Eur J Cancer"},{"issue":"6","key":"zoi221249r40","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/bjc.2011.48","article-title":"HPV self-sampling as an alternative strategy in non-attenders for cervical screening\u2014a randomised controlled trial.","volume":"104","author":"Szarewski","year":"2011","journal-title":"Br J Cancer"},{"issue":"4","key":"zoi221249r41","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Geographic access to cancer care in the U.S.","volume":"112","author":"Onega","year":"2008","journal-title":"Cancer"},{"issue":"6","key":"zoi221249r42","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"zoi221249r45","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"issue":"11","key":"zoi221249r46","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1002\/ijc.v145.11","article-title":"Increasing participation in cervical screening by targeting long-term nonattenders: randomized health services study.","volume":"145","author":"Elfstr\u00f6m","year":"2019","journal-title":"Int J Cancer"},{"key":"zoi221249r47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13027-020-00280-0","article-title":"Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection.","volume":"15","author":"Ernstson","year":"2020","journal-title":"Infect Agent Cancer"},{"issue":"714","key":"zoi221249r48","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.3399\/BJGP.2021.0350","article-title":"Non-speculum sampling approaches for cervical screening in older women: randomised controlled trial.","volume":"72","author":"Landy","year":"2021","journal-title":"Br J Gen Pract"},{"issue":"2","key":"zoi221249r49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ijc.30031","article-title":"Home-based HPV self-sampling improves participation by never-screened and under-screened women: results from a large randomized trial (iPap) in Australia.","volume":"139","author":"Sultana","year":"2016","journal-title":"Int J Cancer"},{"issue":"1","key":"zoi221249r50","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12885-018-4165-4","article-title":"Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures\u2014a randomized controlled trial.","volume":"18","author":"Tranberg","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"zoi221249r51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0969141314558785","article-title":"A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for human papillomavirus testing versus repeat invitation for cervical screening.","volume":"22","author":"Cadman","year":"2015","journal-title":"J Med Screen"},{"issue":"19","key":"zoi221249r52","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2021.6238","article-title":"Screening for colorectal cancer: US Preventive Services Task Force recommendation statement.","volume":"325","author":"Davidson","year":"2021","journal-title":"JAMA"},{"key":"zoi221249r53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106896","article-title":"Does mailing unsolicited HPV self-sampling kits to women overdue for cervical cancer screening impact uptake of other preventive health services in a United States integrated delivery system?","volume":"154","author":"Kariya","year":"2022","journal-title":"Prev Med"},{"issue":"10","key":"zoi221249r54","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/07399330701615358","article-title":"Exploring older women\u2019s approaches to cervical cancer screening.","volume":"28","author":"Guilfoyle","year":"2007","journal-title":"Health Care Women Int"},{"issue":"1","key":"zoi221249r55","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12905-019-0736-z","article-title":"Barriers to cervical screening among older women from hard-to-reach groups: a qualitative study in England.","volume":"19","author":"Marlow","year":"2019","journal-title":"BMC Womens Health"},{"key":"zoi221249r56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ypmed.2017.05.002","article-title":"Psycho-social influences upon older women\u2019s decision to attend cervical screening: a review of current evidence.","volume":"101","author":"Hope","year":"2017","journal-title":"Prev Med"},{"issue":"3","key":"zoi221249r57","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1177\/09691413221092246","article-title":"Self-sampling for cervical screening offered at the point of invitation: a cross-sectional study of preferences in England.","volume":"29","author":"Drysdale","year":"2022","journal-title":"J Med Screen"},{"issue":"1","key":"zoi221249r58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.15430\/JCP.2021.26.1.25","article-title":"Promotion of cervical screening among long-term non-attendees by human papillomavirus self-sampling.","volume":"26","author":"Ernstson","year":"2021","journal-title":"J Cancer Prev"},{"issue":"3","key":"zoi221249r59","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2340\/00015555-0205","article-title":"High prevalence of oncogenic human papilloma virus in women not attending organized cytological screening.","volume":"87","author":"Stenvall","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"zoi221249r60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151978","article-title":"Self-sampling for human papillomavirus testing among non-attenders increases attendance to the Norwegian cervical cancer screening programme.","volume":"11","author":"Enerly","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"zoi221249r61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235202","article-title":"Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women\u2019s own preferred test method into account\u2014a Swedish randomised controlled trial.","volume":"15","author":"Lilliecreutz","year":"2020","journal-title":"PLoS One"},{"key":"zoi221249r62","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ypmed.2017.05.004","article-title":"National assessment of HPV and Pap tests: changes in cervical cancer screening, National Health Interview Survey.","volume":"100","author":"Watson","year":"2017","journal-title":"Prev Med"},{"key":"zoi221249r63","doi-asserted-by":"publisher","DOI":"10.5888\/pcd13.160225","article-title":"Understanding barriers to cervical cancer screening in women with access to care, Behavioral Risk Factor Surveillance System, 2014.","volume":"13","author":"Crawford","year":"2016","journal-title":"Prev Chronic Dis"},{"issue":"6","key":"zoi221249r64","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1159\/000452240","article-title":"Racial\/ethnic disparities in cervical cancer screening and outcomes.","volume":"60","author":"Musselwhite","year":"2016","journal-title":"Acta Cytol"},{"key":"zoi221249r65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106400","article-title":"Cervical cancer screening in the United States: challenges and potential solutions for underscreened groups.","volume":"144","author":"Fuzzell","year":"2021","journal-title":"Prev Med"},{"key":"zoi221249r67","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-021-01184-4","article-title":"HPV testing behaviors and willingness to use HPV self-sampling at home among African American (AA) and Sub-Saharan African Immigrant (SAI) women.","author":"Adegboyega","year":"2021","journal-title":"J Racial Ethn Health Disparities"},{"issue":"6","key":"zoi221249r68","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1007\/s10903-018-0846-y","article-title":"Acceptability, feasibility and uptake of HPV self-sampling among immigrant minority women: a focused literature review.","volume":"21","author":"Marshall","year":"2019","journal-title":"J Immigr Minor Health"},{"issue":"3","key":"zoi221249r69","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/01.JAA.0000819564.35151.0a","article-title":"Barriers to cervical cancer screening among immigrants.","volume":"35","author":"Strelow","year":"2022","journal-title":"JAAPA"},{"issue":"8","key":"zoi221249r70","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.2105\/AJPH.2004.041418","article-title":"Limited English proficiency and breast and cervical cancer screening in a multiethnic population.","volume":"95","author":"Jacobs","year":"2005","journal-title":"Am J Public Health"},{"key":"zoi221249r71","doi-asserted-by":"publisher","first-page":"h2147","DOI":"10.1136\/bmj.h2147","article-title":"The PRECIS-2 tool: designing trials that are fit for purpose.","volume":"350","author":"Loudon","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"zoi221249r72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12963-020-00244-x","article-title":"Comparisons of individual- and area-level socioeconomic status as proxies for individual-level measures: evidence from the Mortality Disparities in American Communities study.","volume":"19","author":"Moss","year":"2021","journal-title":"Popul Health Metr"},{"issue":"1","key":"zoi221249r73","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/jamia\/ocab199","article-title":"The quality of social determinants data in the electronic health record: a systematic review.","volume":"29","author":"Cook","year":"2021","journal-title":"J Am Med Inform Assoc"},{"key":"zoi221249r5","unstructured":"US Centers for Disease Control and Prevention. Cancers associated with human papillomavirus, United States\u20142012\u20132016. May 4, 2022. Accessed May 10, 2022. https:\/\/www.cdc.gov\/cancer\/uscs\/about\/data-briefs\/no10-hpv-assoc-cancers-UnitedStates-2012-2016.htm"},{"key":"zoi221249r43","unstructured":"National Committee for Quality Assurance. Breast cancer screening. 2019. Accessed May 10, 2022. https:\/\/www.ncqa.org\/hedis\/measures\/breast-cancer-screening\/"},{"key":"zoi221249r44","unstructured":"National Committee for Quality Assurance. Colorectal cancer screening. 2019. Accessed May 10, 2022. https:\/\/www.ncqa.org\/hedis\/measures\/colorectal-cancer-screening\/"},{"key":"zoi221249r66","unstructured":"US Centers for Disease Control and Prevention. U.S. cancer statistics: data visualizations. June 2021. Accessed May 10, 2022. https:\/\/www.cdc.gov\/cancer\/dataviz"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2799077\/winer_2022_oi_221249_1669128864.7668.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T07:02:51Z","timestamp":1701500571000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2799077"}},"subtitle":["A Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":73,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.44343","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]}}}